HRP20080146T3 - Preoperative treatment of post operative pain - Google Patents

Preoperative treatment of post operative pain

Info

Publication number
HRP20080146T3
HRP20080146T3 HR20080146T HRP20080146T HRP20080146T3 HR P20080146 T3 HRP20080146 T3 HR P20080146T3 HR 20080146 T HR20080146 T HR 20080146T HR P20080146 T HRP20080146 T HR P20080146T HR P20080146 T3 HRP20080146 T3 HR P20080146T3
Authority
HR
Croatia
Prior art keywords
operative pain
post operative
treatment
preoperative treatment
buprenorphine
Prior art date
Application number
HR20080146T
Other languages
English (en)
Croatian (hr)
Inventor
E. Reidenberg Bruce
A. Spyker Daniel
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of HRP20080146T3 publication Critical patent/HRP20080146T3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Processing Of Meat And Fish (AREA)
HR20080146T 2003-07-25 2004-07-26 Preoperative treatment of post operative pain HRP20080146T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49036303P 2003-07-25 2003-07-25
PCT/US2004/024009 WO2005011578A2 (en) 2003-07-25 2004-07-26 Preoperative treatment of post operative pain

Publications (1)

Publication Number Publication Date
HRP20080146T3 true HRP20080146T3 (en) 2008-04-30

Family

ID=34115386

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080146T HRP20080146T3 (en) 2003-07-25 2004-07-26 Preoperative treatment of post operative pain

Country Status (27)

Country Link
US (3) US20080026042A1 (enExample)
EP (1) EP1638492B1 (enExample)
JP (1) JP5632573B2 (enExample)
KR (4) KR20080011248A (enExample)
CN (1) CN1829489B (enExample)
AT (1) ATE382354T1 (enExample)
AU (1) AU2004261181B2 (enExample)
BR (1) BRPI0412924A (enExample)
CA (1) CA2529983C (enExample)
CY (1) CY1107352T1 (enExample)
DE (1) DE602004011055T2 (enExample)
DK (1) DK1638492T3 (enExample)
EA (1) EA009213B1 (enExample)
ES (1) ES2299871T3 (enExample)
GE (1) GEP201606538B (enExample)
HR (1) HRP20080146T3 (enExample)
IL (1) IL173345A (enExample)
IS (1) IS8186A (enExample)
MA (1) MA28005A1 (enExample)
MX (1) MXPA06000990A (enExample)
NO (1) NO326636B1 (enExample)
NZ (1) NZ594154A (enExample)
PL (1) PL1638492T3 (enExample)
PT (1) PT1638492E (enExample)
UA (1) UA81689C2 (enExample)
WO (1) WO2005011578A2 (enExample)
ZA (1) ZA200510071B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE10361306A1 (de) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
JP2011251944A (ja) * 2010-06-02 2011-12-15 Kansai Medical Univ 埋植用鎮痛製剤
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
ES2688577T3 (es) 2010-09-03 2018-11-05 Zoetis Belgium S.A. Composiciones de buprenorfina en dosis altas y uso como analgésico
RU2459640C2 (ru) * 2010-10-26 2012-08-27 Государственное учреждение здравоохранения "Воронежская областная клиническая больница № 1" Способ послеоперационного обезболивания больных, оперированных под спинальной анестезией
RU2487734C1 (ru) * 2011-11-17 2013-07-20 Анатолий Анатольевич Лаврентьев Способ послеоперационного обезболивания
RU178867U1 (ru) * 2016-05-04 2018-04-20 Общество с ограниченной ответственностью Научно-производственное предприятие "НОК" Вакуумная микроразмерная кристаллизационная ячейка
RU2649961C1 (ru) * 2017-02-28 2018-04-05 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Способ обезболивания после проведения операции кесарева сечения у пациенток с избыточной массой тела
WO2024055006A2 (en) * 2022-09-09 2024-03-14 The Regents Of The University Of California Compositions for preventing transition from acute to chronic pain

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119713A (en) * 1977-02-09 1978-10-10 Sam Carosio Analgesic and anti-inflammatory composition
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
DK0484543T3 (da) * 1990-04-24 1996-01-22 Teijin Ltd Plaster
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
SE9003665D0 (sv) * 1990-11-16 1990-11-16 Kabivitrum Ab Morphine prodrugs
JP2669951B2 (ja) * 1991-03-28 1997-10-29 雍憲 森本 麻薬性鎮痛剤を含有する経皮吸収組成物
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
CA2174803C (en) * 1996-04-23 2000-07-11 Jonathan P. Wong Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug
JPH1036265A (ja) * 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5942530A (en) * 1997-08-28 1999-08-24 Eli Lilly And Company Method for treating pain
KR100383252B1 (ko) * 1998-12-17 2003-07-16 주식회사 삼양사 부프레놀핀을함유하는경피투여조성물및이를포함하는패취
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
JP4659943B2 (ja) * 2000-02-25 2011-03-30 帝三製薬株式会社 塩酸ブプレノルフィン含有貼付剤
AU2001262683A1 (en) * 2000-06-02 2001-12-17 Teijin Limited Buprenorphine-containing patch
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US20020106407A1 (en) * 2000-12-11 2002-08-08 Dennis Coleman Method and apparatus for treating breakthrough pain
DK2113315T3 (da) * 2001-04-23 2014-08-18 Euro Celtique Sa Bortskaffelsessystem til transdermal doseringsform
PT2062573E (pt) * 2001-05-01 2012-01-11 Euro Celtique Sa Sistemas transdérmicos que contêm opióides que resistem a violação
DE60235159D1 (de) * 2001-05-22 2010-03-11 Euro Celtique Sa Behälter und verfahren zum abgeben transdermaler dosierungsformen
MXPA05006334A (es) * 2002-12-13 2005-08-26 Euro Celtique Sa Dosis de buprenorfina transdermica para analgesia.

Also Published As

Publication number Publication date
IS8186A (is) 2005-12-19
EP1638492B1 (en) 2008-01-02
EP1638492A2 (en) 2006-03-29
KR20120128715A (ko) 2012-11-27
CA2529983A1 (en) 2005-02-10
EA200600284A1 (ru) 2006-06-30
KR20080011248A (ko) 2008-01-31
CN1829489A (zh) 2006-09-06
MXPA06000990A (es) 2006-04-11
IL173345A0 (en) 2006-06-11
MA28005A1 (fr) 2006-07-03
GEP201606538B (en) 2016-09-12
JP5632573B2 (ja) 2014-11-26
ATE382354T1 (de) 2008-01-15
DE602004011055T2 (de) 2008-12-18
EP1638492A4 (en) 2006-07-19
AU2004261181B2 (en) 2009-08-06
KR20090031961A (ko) 2009-03-30
KR20060054346A (ko) 2006-05-22
CY1107352T1 (el) 2012-12-19
PT1638492E (pt) 2008-03-17
CN1829489B (zh) 2010-12-15
US20110002975A1 (en) 2011-01-06
HK1087907A1 (en) 2006-10-27
BRPI0412924A (pt) 2006-09-26
US20140221413A1 (en) 2014-08-07
WO2005011578A3 (en) 2005-09-09
NZ594154A (en) 2012-12-21
DE602004011055D1 (de) 2008-02-14
NO326636B1 (no) 2009-01-26
ZA200510071B (en) 2006-11-29
PL1638492T3 (pl) 2008-06-30
AU2004261181A1 (en) 2005-02-10
DK1638492T3 (da) 2008-05-13
EA009213B1 (ru) 2007-12-28
WO2005011578A2 (en) 2005-02-10
JP2007500133A (ja) 2007-01-11
ES2299871T3 (es) 2008-06-01
NO20060912L (no) 2006-04-21
CA2529983C (en) 2010-07-20
IL173345A (en) 2010-06-16
UA81689C2 (ru) 2008-01-25
US20080026042A1 (en) 2008-01-31

Similar Documents

Publication Publication Date Title
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
MXPA05006670A (es) Administracion de capsaicinoides.
DK1587506T3 (da) Administration af capsaicinoider
ATE423560T1 (de) Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form
SE0401345D0 (sv) Therapeutic compounds: Pyridine as scaffold
EA200701131A1 (ru) Гелеобразная препаративная форма капсаициноида и способы её применения
EA200601776A1 (ru) Метадоновые композиции местного действия и способы их применения
TW200635582A (en) Medicaments for the treatment or prevention of fibrotic diseases
SE0401342D0 (sv) Therapeutic compounds
CY1112184T1 (el) Πυριδοξαμινη για χρηση στην αγωγη της διαβητικης nεφροπαθειας στο διαβητη τυπου ii
SE0400184D0 (sv) New therapeutical use
CY1107352T1 (el) Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου
EA200600817A1 (ru) Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты)
ATE541567T1 (de) Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten
AR036009A1 (es) Composicion farmaceutica para el tratamiento o prevencion del dolor visceral y los trastornos gastrointestinales que comprenden un compuesto aminoácido biciclico y uso de este ultimo para fabricar dicha composicion farmaceutica
DK1675611T3 (da) Terapeutiske anvendelser for C-peptid
DE602004029993D1 (de) Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit
WO2007144889A3 (en) Treatment of neurofibromatosis
BRPI0414112A (pt) uso de oxcarbazepina para o tratamento de dor neuropática diabética e a melhora do sono
SE0401343D0 (sv) Therapeutic compounds: Pyridine N oxide as scaffold
DE602006016168D1 (de) 1,3,5-triazepin-dionen zur Behandlung von Malaria
ATE493976T1 (de) Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblicher osteoporose
EA200701086A1 (ru) Производные изоксазола, их фармацевтические композиции и способ лечения невропатической боли
SE0202287D0 (sv) New compounds
NO20043774L (no) The use of devazenide as analgesic agent